Get all your news in one place.

100’s of premium titles.
One app.

Start reading

Get all your news in one place.

100’s of premium titles. One news app.

Start reading

The Latest Breaking News from Nasdaq

MindMed Reports Financial Results For Q1, With Lower Cash Balance Compared To December Last Year

MindMed (NASDAQ: MNMD) announced its financial results for the first quarter of 2022, which ended March 31.

Benzinga

Ryanair CEO Thinks Boeing Management Needs A Reboot: CNBC

Ryanair Holdings plc (NASDAQ:RYAAY) CEO Michael O'Leary following the FY22 results, told CNBC that the company had been "very disappointed with the performance" of Boeing Co (NYSE:BA) from a commercial perspective over the last 12 months. Related: Ryanair FY22 Loss Narrows, Expects To Return To Profitability In FY23 O'Leary called for a shakeup of management at…

Benzinga

Mid-Day Market Update: Dow Edges Higher; Data Storage Shares Surge

U.S. stocks traded mixed midway through trading, with the Dow Jones gaining around 20 points on Monday.

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Insurance Stocks Moving In Monday's Intraday Session

According to Benzinga Pro following are the gainers and losers in Insurance industry for today's Intraday session.

Benzinga

Check Out What Whales Are Doing With AAL

Someone with a lot of money to spend has taken a bearish stance on American Airlines Group (NASDAQ:AAL). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Benzinga

Arcimoto Partners With JOCO For Manhattan Pilot Program

Arcimoto Inc (NASDAQ:FUV) has teamed with Light Electric Vehicle sharing platform JOCO for a pilot program to field test Deliverator, its three-wheel electric vehicle designed for local and last-mile delivery. The vehicle features a top speed of 75 mph, 102 city mile range, 20+ cubic feet of cargo space. JOCO, which operates…

Benzinga

Inventiva Raises €50M Debt Financing To Fund Its Lead Program In NASH Patients

Inventiva (NASDAQ:IVA) has signed a €50 million bullet credit facility agreement with the European Investment Bank. The company plans to use the facility for its preclinical and clinical pipeline, including to help fund a portion of its Phase 3 clinical trial of lanifibranor in patients with non-alcoholic steatohepatitis (NASH). Related: Inventiva Posts Results of…

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Merck, Athenex Join Forces To Evaluate Oraxol/Keytruda Combo In Lung Cancer

Athenex Inc (NASDAQ:ATNX) announced a clinical trial collaboration and supply agreement with Merck Co & Inc (NYSE:MRK). The agreement applies to the expansion phase of the Phase 1 clinical trial evaluating Athenex's oral paclitaxel combined with Merck's Keytruda (pembrolizumab) for certain NSCLC patients. The agreement will support the trial's expansion phase to investigate further the…

Benzinga

41 Stocks Moving In Monday's Mid-Day Session

Gainers Data Storage Corporation (NASDAQ: DTST) shares jumped 51.1% to $3.4750 after the company reported better-than-expected Q1 financial results.

Benzinga

eBay, FedEx Extend Alliance In Canada - Read Why

eBay Inc (NASDAQ:EBAY) and FedEx Corp (NYSE:FDX) extend their alliance in Canada for shipping labels platform integration. The partnership will enable Canadian sellers to access FedEx shipping services directly through eBay Labels. "With this extended FedEx alliance, we're making shipping even easier and more cost-effective for our eBay sellers, which in turn allows them to…

Benzinga

4 Analysts Have This to Say About EVgo

Within the last quarter, EVgo (NASDAQ:EVGO) has observed the following analyst ratings:

Benzinga

Expert Ratings for Applied Materials

Analysts have provided the following ratings for Applied Materials (NASDAQ:AMAT) within the last quarter:

Benzinga

Trump SPAC Deal Finally Files A Proxy: 10 Key Details We Now Know

Seven months after announcing a SPAC merger, a social media company owned by former President Donald Trump has filed its proxy. Here are the key details from the more than 250 pages contained in the proxy filing.

Benzinga

What 6 Analyst Ratings Have To Say About Bandwidth

Analysts have provided the following ratings for Bandwidth (NASDAQ:BAND) within the last quarter:

Benzinga

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

Credit Suisse Maintains Outperform Rating for Cisco Systems: Here's What You Need To Know

Credit Suisse has decided to maintain its Outperform rating of Cisco Systems (NASDAQ:CSCO) and lower its price target from $73.00 to $72.00. Shares of Cisco Systems are trading down 0.14% over the last 24 hours, at $49.49 per share.

Benzinga

DA Davidson Maintains Buy Rating for AEye: Here's What You Need To Know

DA Davidson has decided to maintain its Buy rating of AEye (NASDAQ:LIDR) and lower its price target from $15.00 to $12.00. Shares of AEye are trading up 9.45% over the last 24 hours, at $5.38 per share. A move to $12.00 would account for a 122.84% increase from the current…

Benzinga

HC Wainwright & Co. Maintains Buy Rating for Motus GI Hldgs: Here's What You Need To Know

HC Wainwright & Co. has decided to maintain its Buy rating of Motus GI Hldgs (NASDAQ:MOTS) and lower its price target from $2.00 to $1.50. Shares of Motus GI Hldgs are trading up 2.97% over the last 24 hours, at $0.27 per share.

Benzinga

Veru Whale Trades For May 16

A whale with a lot of money to spend has taken a noticeably bearish stance on Veru. Looking at options history for Veru (NASDAQ:VERU) we detected 14 strange trades.

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

Compass Point Maintains Neutral Rating for AFC Gamma: Here's What You Need To Know

Compass Point has decided to maintain its Neutral rating of AFC Gamma (NASDAQ:AFCG) and lower its price target from $20.00 to $17.50. Shares of AFC Gamma are trading down 4.66% over the last 24 hours, at $17.00 per share. A move to $17.50 would account for a 2.94% increase from…

Benzinga

Piper Sandler Maintains Neutral Rating for Pacific Biosciences: Here's What You Need To Know

Piper Sandler has decided to maintain its Neutral rating of Pacific Biosciences (NASDAQ:PACB) and lower its price target from $13.00 to $6.00. Shares of Pacific Biosciences are trading down 2.74% over the last 24 hours, at $5.68 per share.

Benzinga

Cowen & Co. Maintains Outperform Rating for DarioHealth: Here's What You Need To Know

Cowen & Co. has decided to maintain its Outperform rating of DarioHealth (NASDAQ:DRIO) and raise its price target from $14.00 to $18.00. Shares of DarioHealth are trading up 5.8% over the last 24 hours, at $6.20 per share.

Benzinga

Here's Why Surgalign Holdings Shares Are Falling Today

Surgalign Holdings Inc (NASDAQ: SRGA) shares are trading lower by 19.73% at $0.15 after the company announced a 1-for-30 reverse stock split. The 1-for-30 reverse stock split will take effect at the opening of trading on the Nasdaq Global Select Market on Tuesday.

Benzinga

C4 Therapeutics Doses First Patient in Phase 1/2 Trial of CFT8634 For SMARCB1-perturbed cancers

C4 Therapeutics, Inc. (C4T) (NASDAQ: CCCC) has dosed the first patient in the Phase 1/2 clinical trial of its drug candidate CFT8634, for the treatment of SMARCB1-perturbed cancers, including synovial sarcoma and SMARCB1-null tumors.

Benzinga

Orbital Energy Stock Gains After Q1 Results; Reiterates FY22 Forecast

Orbital Energy Group Inc (NASDAQ:OEG) reported first-quarter revenue of $70.25 million, compared to $5.56 million in 1Q21, marginally missing the consensus of $70.49 million. EPS loss widened to $(0.44) from $(0.36) in 1Q21, missing the consensus of $(0.05). OEG reported a gross profit of $11.58 million, compared to a loss of $(2.52)…

Benzinga

What's Going On With Sundial Growers Stock?

Sundial Growers Inc (NASDAQ: SNDL) shares are trading significantly higher Monday ahead of the company's first-quarter financial results, which are set to be released after the bell.

1 … 474 475 476 477

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.